Molina Healthcare, Inc. (MOH) 10-Year Financial Performance & Capital Metrics

MOH • • Insurance & Managed Care

HealthcareHealth InsuranceGovernment Program SpecialistsMedicaid & Public Program Focused

AboutMolina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.Show more

Revenue $40.65B +19.3%
Combined Ratio 95.8% +0.4%
Net Income $1.18B +8.1%
Return on Equity 27.07% -10.9%
Medical Cost Ratio 88.35% +1.2%
Operating Margin 4.2% -9.0%
Net Margin 2.9% -9.4%
ROA 7.73% -3.7%
Equity / Assets 28.77% +1.6%
Book Value per Share 77.92 +7.4%
Tangible BV/Share 44.33 -6.9%
Debt/Equity 0.69 +22.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 28.6%

✗Weaknesses

✗High loss ratio of 88.3%
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y15.45%

5Y19.29%

3Y13.54%

TTM37.93%

Profit (Net Income) CAGR

10Y34.2%

5Y9.85%

3Y21.4%

TTM-22.81%

EPS CAGR

10Y31.81%

5Y12.21%

3Y21.98%

TTM-18.54%

ROCE

10Y Avg19.76%

5Y Avg23.83%

3Y Avg23.84%

Latest23.61%

Peer Comparison

Medicaid & Public Program Focused

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
MOHMolina Healthcare, Inc.	9.96B	193.74	9.49	19.31%	1.63%	21.07%	5.46%	0.69
CNCCentene Corporation	23.23B	47.27	7.49	5.89%	-2.85%	-25.12%		0.73

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	14.07B	17.71B	19.88B	18.89B	16.83B	19.42B	27.77B	31.97B	34.07B	40.65B
Revenue Growth %	0.46%	0.26%	0.12%	-0.05%	-0.11%	0.15%	0.43%	0.15%	0.07%	0.19%
Medical Costs & Claims+	12.43B	15.94B	18B	16.27B	14.39B	16.75B	24.49B	28.05B	29.74B	35.91B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	1.64B	1.77B	1.88B	2.62B	2.44B	2.68B	3.28B	3.93B	4.33B	4.74B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.56%	0.08%	0.06%	0.4%	-0.07%	0.1%	0.23%	0.2%	0.1%	0.09%
Operating Expenses+	1.25B	1.53B	19.95B	17.01B	1.39B	1.6B	2.26B	2.75B	2.76B	3.03B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	126M	182M	178M	127M	89M	88M	131M	176M	171M	186M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	387M	306M	-555M	1.13B	1.04B	1.08B	1.02B	1.17B	1.57B	1.71B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	1.01%	-0.21%	-2.81%	3.04%	-0.08%	0.03%	-0.05%	0.15%	0.34%	0.09%
EBITDA+	513M	488M	-377M	1.26B	1.13B	1.17B	1.15B	1.35B	1.74B	1.89B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	66M	101M	118M	115M	87M	102M	120M	110M	109M	118M
Non-Operating Income	-1M	0	-61M	17M	-15M	15M	25M	0	0	0
Pretax Income+	322M	137M	-612M	999M	972M	961M	875M	1.06B	1.46B	1.59B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	179M	129M	-100M	292M	235M	288M	216M	271M	373M	410M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	143M	8M	-512M	707M	737M	673M	659M	792M	1.09B	1.18B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	1.3%	-0.94%	-65%	2.38%	0.04%	-0.09%	-0.02%	0.2%	0.38%	0.08%
EPS (Diluted)+	2.58	0.92	-9.14	10.55	11.48	11.24	11.25	13.54	18.78	20.42
EPS Growth %	1%	-0.64%	-10.93%	2.15%	0.09%	-0.02%	0%	0.2%	0.39%	0.09%
EPS (Basic)	2.75	0.93	-9.14	10.61	11.85	11.41	11.40	13.70	18.71	20.52
Diluted Shares Outstanding	56M	56M	56M	67M	64.2M	59.9M	58.6M	58.5M	58.1M	57.7M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	6.58B	7.45B	8.47B	7.15B	6.79B	9.53B	12.21B	12.31B	14.89B	15.63B
Asset Growth %	0.48%	0.13%	0.14%	-0.16%	-0.05%	0.4%	0.28%	0.01%	0.21%	0.05%
Total Investment Assets+	1.91B	1.87B	2.64B	1.8B	2.02B	1.88B	3.2B	3.5B	4.26B	4.33B
Long-Term Investments	109M	110M	119M	120M	79M	0	0	0	0	0
Short-Term Investments	1.8B	1.76B	2.52B	1.68B	1.95B	1.88B	3.2B	3.5B	4.26B	4.33B
Total Current Assets+	5.31B	5.99B	7.51B	6.46B	5.97B	7.88B	10.06B	10.08B	12.54B	12.77B
Cash & Equivalents	2.33B	2.82B	3.19B	2.83B	2.45B	4.15B	4.44B	4.01B	4.85B	4.66B
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	374M	267M	691M	476M	0	0	0	277M	331M	487M
Goodwill & Intangibles+	641M	759M	255M	190M	172M	941M	1.25B	1.39B	1.45B	1.94B
Goodwill	519M	620M	186M	143M	143M	692M	982M	1.11B	1.24B	1.67B
Intangible Assets	122M	140M	69M	47M	29M	249M	270M	275M	208M	267M
PP&E (Net)	393M	454M	342M	241M	385M	391M	396M	259M	270M	288M
Other Assets	109M	127M	141M	24M	105M	255M	391M	361M	404M	424M
Total Liabilities	5.02B	5.8B	7.13B	5.51B	4.83B	7.44B	9.58B	9.35B	10.68B	11.13B
Total Debt+	1.61B	1.65B	2.17B	1.46B	1.49B	2.35B	2.39B	2.39B	2.38B	3.12B
Net Debt	-720M	-1.17B	-1.02B	-1.37B	-966M	-1.8B	-2.05B	-1.61B	-2.46B	-1.54B
Long-Term Debt	962M	975M	1.32B	1.02B	1.24B	2.13B	2.17B	2.18B	2.18B	2.92B
Short-Term Debt	449M	471M	652M	240M	18M	0	0	0	0	0
Total Current Liabilities+	3.82B	4.57B	5.56B	4.25B	3.27B	4.96B	7.05B	6.86B	8.17B	7.9B
Accounts Payable	362M	385M	366M	390M	502M	641M	842M	889M	1.25B	1.33B
Deferred Revenue	223M	315M	282M	211M	249M	375M	370M	359M	418M	51M
Other Current Liabilities	374M	267M	522M	476M	-18M	0	0	0	0	0
Deferred Taxes	0	1000K	0	0	0	0	0	0	0	0
Other Liabilities	37M	42M	61M	44M	90M	119M	140M	104M	124M	120M
Total Equity+	1.56B	1.65B	1.34B	1.65B	1.96B	2.1B	2.63B	2.96B	4.21B	4.5B
Equity Growth %	0.54%	0.06%	-0.19%	0.23%	0.19%	0.07%	0.25%	0.13%	0.42%	0.07%
Shareholders Equity	1.56B	1.65B	1.34B	1.65B	1.96B	2.1B	2.63B	2.96B	4.21B	4.5B
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	758M	810M	298M	1.01B	1.78B	1.86B	2.4B	2.8B	3.89B	4.09B
Common Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-4M	-2M	-5M	-8M	4M	37M	-5M	-160M	-82M	-57M
Return on Equity (ROE)	0.11%	0%	-0.34%	0.47%	0.41%	0.33%	0.28%	0.28%	0.3%	0.27%
Return on Assets (ROA)	0.03%	0%	-0.06%	0.09%	0.11%	0.08%	0.06%	0.06%	0.08%	0.08%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	1.03x	1.00x	1.62x	0.89x	0.76x	1.12x	0.91x	0.81x	0.57x	0.69x
Book Value per Share	27.80	29.45	23.88	24.58	30.53	34.99	44.88	50.67	72.55	77.92
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.13B	673M	804M	-314M	427M	1.89B	2.12B	773M	1.66B	644M
Operating CF Growth %	0.06%	-0.4%	0.19%	-1.39%	2.36%	3.43%	0.12%	-0.64%	1.15%	-0.61%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	143M	8M	-512M	707M	737M	673M	659M	792M	1.09B	1.18B
Depreciation & Amortization	126M	182M	178M	127M	89M	88M	131M	176M	171M	186M
Stock-Based Compensation	23M	26M	46M	27M	39M	57M	72M	103M	115M	116M
Deferred Taxes	-7M	22M	-94M	-6M	10M	-19M	-24M	-66M	-31M	53M
Other Non-Cash Items	49M	47M	597M	80M	-15M	27M	58M	216M	2M	8M
Working Capital Changes	791M	388M	589M	-1.25B	-433M	1.06B	1.22B	-448M	314M	-898M
Cash from Investing+	-1.42B	-202M	-1.07B	1.14B	-293M	-400M	-1.65B	-790M	-744M	-464M
Capital Expenditures	-132M	-176M	-86M	-30M	-57M	-74M	-77M	-91M	-84M	-100M
Acquisitions	-450M	-48M	0	190M	0	-755M	-129M	-134M	-3M	-344M
Purchase of Investments	-1.92B	-1.93B	-2.72B	-1.44B	-2.54B	-670M	-2.71B	-1.91B	-1.43B	-1.13B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-41M	-15M	-40M	-18M	-2M	2M	-63M	-50M	4M	1M
Cash from Financing+	1.08B	19M	636M	-1.19B	-552M	217M	-183M	-441M	-58M	-347M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	-47M	-606M	-128M	-400M	-60M	-1B
Stock Issued	391M	18M	19M	0	0	0	0	0	0	0
Debt Issuance (Net)	1000K	0	1000K	-1000K	-1000K	1000K	1000K	0	0	1000K
Other Financing	5M	1M	-8M	-531M	-485M	-36M	-19M	-41M	2M	-87M
Net Change in Cash+	790M	490M	367M	-364M	-418M	1.72B	283M	-458M	860M	-167M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	1.54B	2.33B	2.82B	3.29B	2.93B	2.51B	4.22B	4.51B	4.05B	4.91B
Cash at End	2.33B	2.82B	3.19B	2.93B	2.51B	4.22B	4.51B	4.05B	4.91B	4.74B
Free Cash Flow+	993M	497M	718M	-344M	370M	1.82B	2.04B	682M	1.58B	544M
FCF Growth %	0.05%	-0.5%	0.44%	-1.48%	2.08%	3.91%	0.12%	-0.67%	1.31%	-0.66%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	17.73	8.88	12.82	-5.13	5.76	30.32	34.85	11.66	27.16	9.43

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	97.25%	98.66%	190.86%	176.17%	93.76%	94.45%	96.33%	96.33%	95.38%	95.8%
Medical Cost Ratio	88.36%	90.01%	90.54%	86.11%	85.53%	86.22%	88.19%	87.72%	87.28%	88.35%
Return on Equity (ROE)	11.14%	0.5%	-34.29%	47.39%	40.87%	33.19%	27.89%	28.32%	30.39%	27.07%
Return on Assets (ROA)	2.6%	0.11%	-6.43%	9.05%	10.57%	8.25%	6.06%	6.46%	8.02%	7.73%
Equity / Assets	23.68%	22.14%	15.78%	23.02%	28.88%	21.99%	21.54%	24.07%	28.3%	28.77%
Book Value / Share	27.8	29.45	23.88	24.58	30.53	34.99	44.88	50.67	72.55	77.92
Debt / Equity	1.03x	1.00x	1.62x	0.89x	0.76x	1.12x	0.91x	0.81x	0.57x	0.69x
Revenue Growth	45.57%	25.86%	12.26%	-4.99%	-10.91%	15.41%	42.98%	15.13%	6.56%	19.31%

Revenue by Segment

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2024
Medicaid Solutions	210.05M	195M	195M	187M	-	-	-	21.23B	25.78B	30.58B
Medicaid Solutions Growth	-	-7.17%	0.00%	-4.10%	-	-	-	-	21.44%	18.60%
Medicare	-	-	-	-	-	-	-	3.38B	3.82B	5.54B
Medicare Growth	-	-	-	-	-	-	-	-	13.17%	44.93%
Marketplace	-	-	-	-	-	-	-	3.09B	2.3B	2.51B
Marketplace Growth	-	-	-	-	-	-	-	-	-25.72%	9.15%
Others	-	66M	353M	344M	-	14M	8M	70M	71M	81M
Others Growth	-	-	434.85%	-2.55%	-	-	-42.86%	775.00%	1.43%	14.08%
Health Plans	-	-	-	-	2.04B	-	-	-	-	-
Health Plans Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Molina Healthcare, Inc. (MOH) has a price-to-earnings (P/E) ratio of 9.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Molina Healthcare, Inc. (MOH) grew revenue by 19.3% over the past year. This is strong growth.

Yes, Molina Healthcare, Inc. (MOH) is profitable, generating $883.0M in net income for fiscal year 2024 (2.9% net margin).

Dividend & Returns

Molina Healthcare, Inc. (MOH) has a return on equity (ROE) of 27.1%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

Molina Healthcare, Inc. (MOH) has a combined ratio of 95.8%. A ratio below 100% indicates underwriting profitability.

← Back to Screener

US Stock Screener

...